BOUCHALOVÁ, Pavla, Lucia SOMMEROVÁ, David POTĚŠIL, Andrea MARTIŠOVÁ, Petr LAPČÍK, Veronika BRYCHTOVÁ, Alexander SCHERL, Petr VOŇKA, Joan PLANAS IGLESIAS, Eric CHEVET, Pavel BOUCHAL and Roman HRSTKA. Characterization of the AGR2 Interactome Uncovers New Players of Protein Disulfide Isomerase Network in Cancer Cells. Molecular & Cellular Proteomics. American Society for Biochemistry and Molecular Biology, 2022, vol. 21, No 2, p. 1-19. ISSN 1535-9484. Available from: https://dx.doi.org/10.1016/j.mcpro.2021.100188.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Characterization of the AGR2 Interactome Uncovers New Players of Protein Disulfide Isomerase Network in Cancer Cells
Authors BOUCHALOVÁ, Pavla (203 Czech Republic, belonging to the institution), Lucia SOMMEROVÁ (703 Slovakia), David POTĚŠIL (203 Czech Republic, belonging to the institution), Andrea MARTIŠOVÁ (703 Slovakia, belonging to the institution), Petr LAPČÍK (203 Czech Republic, belonging to the institution), Veronika BRYCHTOVÁ (203 Czech Republic), Alexander SCHERL (756 Switzerland), Petr VOŇKA (203 Czech Republic), Joan PLANAS IGLESIAS (724 Spain, belonging to the institution), Eric CHEVET (250 France), Pavel BOUCHAL (203 Czech Republic, guarantor, belonging to the institution) and Roman HRSTKA (203 Czech Republic).
Edition Molecular & Cellular Proteomics, American Society for Biochemistry and Molecular Biology, 2022, 1535-9484.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 10608 Biochemistry and molecular biology
Country of publisher Netherlands
Confidentiality degree is not subject to a state or trade secret
WWW URL
Impact factor Impact factor: 7.000
RIV identification code RIV/00216224:14310/22:00125142
Organization unit Faculty of Science
Doi http://dx.doi.org/10.1016/j.mcpro.2021.100188
UT WoS 000750798300001
Keywords in English anterior gradient protein 2; protein-protein interactions; protein disulfide isomerase; mass spectrometry; secretory pathway
Tags CF PROT, rivok
Tags International impact, Reviewed
Changed by Changed by: Mgr. Marie Šípková, DiS., učo 437722. Changed: 23/3/2023 08:31.
Abstract
AGR2 is an endoplasmic reticulum (ER)-resident protein disulfide isomerase (PDI) known to be overexpressed in many human epithelial cancers, and is involved in cell migration, cellular transformation, angiogenesis, and metastasis. This protein inhibits the activity of the tumor suppressor p53 and its expression levels can be used to predict cancer patient outcome. However, the precise network of AGR2-interacting partners and clients remains to be fully characterized. Herein, we used label-free quantification and also SILAC-based LC-MS/MS analyses to identify proteins interacting with AGR2. Functional annotation confirmed that AGR2 and its interaction partners are associated with processes in the ER that maintain intracellular metabolic homeostasis and participate in the unfolded protein response, including those associated with changes in cellular metabolism, energy, and redox states in response to ER stress. As a proof of concept, the interaction between AGR2 and PDIA3, another ER resident PDI, was studied in more detail. Pathway analysis revealed that AGR2 and PDIA3 play roles in protein folding in ER, including posttranslational modification and in cellular response to stress. We confirmed the AGR2-PDIA3 complex formation in cancer cells, which was enhanced in response to ER stress. Accordingly, molecular docking characterized potential quaternary structure of this complex, however, it remains to be elucidated whether (i) AGR2 rather contributes to PDIA3 maturation in ER, (ii) the complex directly acts in cellular signaling, or (iii) mediates AGR2 secretion. Our study provides a comprehensive insight into the protein-protein interaction network of AGR2 by identifying functionally relevant proteins and related cellular and biochemical pathways associated with the role of AGR2 in cancer cells.
Links
LM2018127, research and development projectName: Česká infrastruktura pro integrativní strukturní biologii (Acronym: CIISB)
Investor: Ministry of Education, Youth and Sports of the CR
MUNI/A/1604/2020, interní kód MUName: Podpora biochemického výzkumu v roce 2021
Investor: Masaryk University
NV19-08-00250, research and development projectName: Proteotypová klasifikace renálního karcinomu ve vztahu k prognóze a terapeutické odpovědi
Investor: Ministry of Health of the CR
90125, large research infrastructuresName: BBMRI-CZ III
PrintDisplayed: 8/5/2024 00:18